Peter Verdult

Item: Peter Verdult
Rating: 0.44
Author: StockAnalysis.com

Stock Analyst at Citigroup

(0.44)

# 4,164

Out of 5,058 analysts

Total ratings

33.33%

Success rate

-15.47%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Peter Verdult

Stock	Action	Price Target	Current	Upside	Ratings	Updated
LLY Eli Lilly and Company	Maintains: Buy	$1,250 → $1,500	$1,043.29	+43.78%	4	Nov 12, 2025
EVO Evotec SE	Upgrades: Buy	n/a	$2.90	-	1	Jun 8, 2023
GLPG Galapagos NV	Upgrades: Buy	n/a	$30.24	-	1	Jan 27, 2022

Eli Lilly and Company

Nov 12, 2025

Maintains: Buy

Price Target: $1,250 → $1,500

Current: $1,043.29

Upside: +43.78%

Evotec SE

Jun 8, 2023

Upgrades: Buy

Price Target: n/a

Current: $2.90

Upside: -

Galapagos NV

Jan 27, 2022

Upgrades: Buy

Price Target: n/a

Current: $30.24

Upside: -